STERIS plc (STE)
NYSE: STE · Real-Time Price · USD
202.61
+3.21 (1.61%)
Jun 18, 2026, 4:00 PM EDT - Market closed
STERIS Revenue
In the fiscal year ending March 31, 2026, STERIS had annual revenue of $5.94B with 8.73% growth. STERIS had revenue of $1.59B in the quarter ending March 31, 2026, with 7.29% growth.
Revenue (ttm)
$5.94B
Revenue Growth
+8.73%
P/S Ratio
3.33
Revenue / Employee
$330,930
Employees
17,937
Market Cap
19.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 5.94B | 476.40M | 8.73% |
| Mar 31, 2025 | 5.46B | 320.80M | 6.24% |
| Mar 31, 2024 | 5.14B | -3.93B | -43.36% |
| Mar 31, 2023 | 9.07B | 625.72M | 7.41% |
| Mar 31, 2022 | 8.45B | 5.34B | 171.82% |
| Mar 31, 2021 | 3.11B | 76.62M | 2.53% |
| Mar 31, 2020 | 3.03B | 248.73M | 8.94% |
| Mar 31, 2019 | 2.78B | 162.17M | 6.19% |
| Mar 31, 2018 | 2.62B | 7.24M | 0.28% |
| Mar 31, 2017 | 2.61B | 374.00M | 16.71% |
| Mar 31, 2016 | 2.24B | 388.50M | 21.00% |
| Mar 31, 2015 | 1.85B | 228.01M | 14.06% |
| Mar 31, 2014 | 1.62B | 120.35M | 8.01% |
| Mar 31, 2013 | 1.50B | 95.09M | 6.76% |
| Mar 31, 2012 | 1.41B | 199.36M | 16.51% |
| Mar 31, 2011 | 1.21B | -50.28M | -4.00% |
| Mar 31, 2010 | 1.26B | -40.80M | -3.14% |
| Mar 31, 2009 | 1.30B | 33.44M | 2.64% |
| Mar 31, 2008 | 1.27B | 67.68M | 5.65% |
| Mar 31, 2007 | 1.20B | 37.12M | 3.20% |
| Mar 31, 2006 | 1.16B | 78.62M | 7.27% |
| Mar 31, 2005 | 1.08B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GE HealthCare Technologies | 20.98B |
| Koninklijke Philips | 20.34B |
| Zimmer Biomet Holdings | 8.41B |
| Smith & Nephew | 6.16B |
| DexCom | 4.82B |
| Bruker | 3.46B |
| Globus Medical | 3.10B |
| Insulet | 2.90B |
STE News
- 8 days ago - STERIS Proxy statement: Proxy filing - Filings
- 8 days ago - STERIS Proxy statement: Proxy filing - Filings
- 5 weeks ago - Steris price target lowered to $269 from $291 at KeyBanc - TheFly
- 5 weeks ago - STERIS Earnings Call Transcript: Q4 2026 - Transcripts
- 5 weeks ago - STERIS Earnings release: Q4 2026 - Filings
- 5 weeks ago - STERIS Annual report: Q4 2026 - Filings
- 5 weeks ago - STERIS Slides: Investor presentation - Filings
- 5 weeks ago - Steris reports Q4 adjusted EPS $2.83, consensus $2.85 - TheFly